Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Perinatal corticosteroids and the developing lung.

Alan T Gibson1

  • 1North Trent Neonatal Intensive Care Unit, Jessop Wing, Sheffield Teaching Hospitals NHS Trust, Tree Root Walk, Sheffield S10 2SF, UK. A.T.Gibson@Sheffield.ac.uk

Paediatric Respiratory Reviews
|June 18, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcome following preterm birth.

Best practice & research. Clinical obstetrics & gynaecology·2007
Same author

The contributions of plasma IGF-I, IGFBP-3 and leptin to growth in extremely premature infants during the first two years.

Pediatric research·2007
Same author

Adaptation of the Carter method to adjust lumbar spine bone mineral content for age and body size: application to children who were born preterm.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2006
Same author

Measurement and the newborn infant.

Hormone research·2003
Same journal

Image-guided pediatric airway endoscopy: A review.

Paediatric respiratory reviews·2026
Same journal

Bronchoscopic and interventional management of tracheobronchomalacia in children with bronchopulmonary dysplasia: a review of evidence.

Paediatric respiratory reviews·2026
Same journal

Bronchopulmonary dysplasia associated pulmonary hypertension: implications across the lifespan.

Paediatric respiratory reviews·2026
Same journal

How to monitor response to biologics in children with severe asthma.

Paediatric respiratory reviews·2026
Same journal

Moving the goalposts from symptom control to preventing airway remodeling in preschool asthma.

Paediatric respiratory reviews·2026
Same journal

Diagnosis of fungal respiratory infections in immunocompetent children.

Paediatric respiratory reviews·2026
See all related articles

Antenatal corticosteroids reduce infant mortality and respiratory distress. However, postnatal corticosteroid use for chronic lung disease in premature infants has questionable benefits and significant long-term risks.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Pharmacology

Background:

  • Premature infants often develop respiratory disease and chronic lung disease, leading to high mortality and morbidity.
  • Antenatal corticosteroid administration to mothers significantly reduces infant mortality, respiratory distress syndrome, and intracranial hemorrhage.
  • Postnatal corticosteroids have been a long-standing treatment for chronic lung disease in premature infants.

Purpose of the Study:

  • To evaluate the current understanding of corticosteroid use in premature infants.
  • To critically assess the benefits versus the risks of postnatal corticosteroid therapy.
  • To examine recent evidence questioning the established cost-benefit ratio of this treatment.

Main Methods:

  • Review of recent meta-analyses on postnatal corticosteroid efficacy.

Related Experiment Videos

  • Analysis of data on the side-effects of corticosteroid treatment.
  • Evaluation of long-term adverse effects reported in recent studies.

    • Main Results:

    • Recent meta-analyses indicate limited benefits of postnatal corticosteroids for chronic lung disease.
    • Corticosteroid treatment is associated with various side-effects.
    • Emerging evidence highlights significant and permanent long-term adverse effects.

    Conclusions:

    • The traditional assumption that the benefits of postnatal corticosteroids outweigh the risks is now questionable.
    • Further research is needed to re-evaluate the risk-benefit profile of long-term corticosteroid use in premature infants.
    • Clinical practice regarding postnatal corticosteroids requires re-evaluation in light of new evidence.